Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 41 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI from Sint-Lambrechts-Woluwe, company number BE0408292992, closed financial year 2025 with a result of € 10.3 million after tax. For that financial year EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI recorded revenue of € 52.3 million and equity of € 90.4 million. Compared with financial year 2024, the result moved from € 6.7 million to € 10.3 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 90.4 million
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10.3 million
▲ 55% vs 2024
Profit after tax over the fiscal year.
€ 6.6 million
▼ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
220.3
▲ 2.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 21.9 million
▲ 5% vs 2024
€ 99,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 369,074
▼ 1% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 7.4 million
▼ 9% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 130 days on average.
€ 5.8 million
▼ 1% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 35,077,819 | € 47,175,973 | € 51,347,591 | € 52,290,507 | ▲ 2% |
| Profit after taxes | € -4,543,919 | € 6,226,885 | € 6,681,719 | € 10,330,543 | ▲ 55% |
| Equity | € 67,180,262 | € 73,407,147 | € 80,088,867 | € 90,419,410 | ▲ 13% |
| Total debts | € 54,142,521 | € 56,013,148 | € 56,952,333 | € 44,339,636 | ▼ 22% |
| Cash | € 30,750,397 | € 7,336,153 | € 8,372,643 | € 6,564,680 | ▼ 22% |
| Retained profit | € 48,094,560 | € 54,321,445 | € 61,003,165 | € 71,333,708 | ▲ 17% |
| Balance sheet total | € 122,073,327 | € 129,985,139 | € 137,547,670 | € 135,167,846 | ▼ 2% |
| Employees (FTE) | 235.8 | 230.7 | 217.8 | 220.3 | ▲ 2.5 |
Key figures of EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI?
What happened at EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Denis Lacombe stepped down as director. NBB
- Etienne Brain stepped down as director. NBB
- Caroline Artis stepped down as director. NBB
- Mieke Van Hemelrijck stepped down as director. NBB
- Vassilis Golfinopoulos stepped down as director. NBB
- Roberto Salgado stepped down as director. NBB
- Jean-Pascal Henry Machiels stepped down as director. NBB
- Elizabeth Eisenhauer stepped down as director. NBB
In short
From € 4.5 million loss in 2022 to € 10.3 million profit in 2025.
Paid € 10.6 million in corporate taxes since 2022.
Best year ever: 2025, with € 10.3 million profit.
Pays suppliers within 130 days on average.
A new publication or filing at EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI? We notify you, reason included.
Follow EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANIDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Denis Lacombe
Personne déléguée à la gestion journalière
since 2024 · until 2027
Etienne Brain
Director
since 2024 · until 2027
Caroline Artis
Director
since 2024 · until 2027
Mieke Van Hemelrijck
Director
since 2024 · until 2027
Vassilis Golfinopoulos
Personne déléguée à la gestion journalière
since 2024 · until 2027
Roberto Salgado
Director
since 2024 · until 2027
Jean-Pascal Henry Machiels
Director
since 2024 · until 2027
Elizabeth Eisenhauer
Director
since 2024 · until 2027
Diego du Monceau
Director
since 2024 · until 2027
Benjamin Besse
Director
since 2024 · until 2027
Wilhelmina van der Graaf
Chairman of the board
since 2024 · until 2027
Anne-Marie Dingemans
Director
since 2024 · until 2027
Establishments
Establishment units
Physical locations of this company
Emmanuel Mounierlaan 83 box 11
1200 Sint-Lambrechts-Woluwe
Emmanuel Mounierlaan 83
1200 Sint-Lambrechts-Woluwe
Active since 18 January 2003
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
eortc.org
Registered
2003-07-31
Registrar
EuroDNS S.A.
Expires
2030-07-31
Website info
Features
Security
Details
- Company number
- 0408.292.992
- VAT number
- BE 0408.292.992
- Registered office
- Emmanuel Mounierlaan 83 bus 11, 1200 Sint-Lambrechts-Woluwe
- Names & denominations
- EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI · EORTC
- Enterprise type
- Rechtspersoon
- Legal form
- International non-profit association
- Legal situation
- Normale toestand
- Start date
- 18 June 1963
- Peppol
- Active · Active since 21 Aug 2025
- Contact
- eortc.org [email protected] 02/774.16.11
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied